ALTERED SEROTONIN IN OBESITY--ONTOGENY AND MECHANISMS
肥胖中血清素的改变——个体发生和机制
基本信息
- 批准号:2805633
- 负责人:
- 金额:$ 3.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-07-01 至 2001-06-30
- 项目状态:已结题
- 来源:
- 关键词:RNase protection assay adipose tissue bioenergetics biological signal transduction body composition brown fat developmental genetics gene expression genetic models genetic strain genotype hyperinsulinism hypothalamus laboratory rat microdialysis neural transmission neurotransmitter metabolism neurotransmitter transport newborn animals nutrition related tag obesity serotonin serotonin receptor sympathetic nervous system thermogenesis
项目摘要
Obesity in humans remains a significant health problem in the United
States. Research with humans and with animal models has established that
obesity is multifaceted, involving altered energy expenditure and
altered energy intake. Recent work has also shown that genetic
background contributes to the development of obesity in humans and
illustrates the complexity of this disorder. Despite this complexity,
many of the metabolic alterations that are seen in obesity are
consistent with altered activity of the sympathetic and parasympathic
nervous systems. This proposal focuses on one aspect of this altered
activity -- the serotonergic input to the ventromedial nucleus (VMN) of
the hypothalamus which has been shown to be reduced in obese Zucker
rats. The two major objectives of this proposal are related to the
general theme that altered VMN serotonergic activity is an important
contributor to the altered regulation of energy balance that occurs in
obesity.
The first objective of this study is to determine if the altered VMN
serotonergic activity of obese rats occurs before increased adiposity,
decreased thermogenesis, or hyperinsulinemia. For this, we will examine
2, 4, 7 and 12 day old Zucker/Brown Norway (ZBN) obese (fafa) vs. lean
(Fafa) pups. The use of ZBN pups, rather than Zucker pups, allows one
to distinguish fafa from Fafa littermates at any age because of the
presence of a restriction fragment length polymorphism closely linked
to the fa locus. This is a major advantage of the ZBN hybrids because
it has not been possible to reliably distinguish fafa from Fafa pups in
the Zucker strain before day 7 of age. The ontogeny data from the ZBN
pups will indicate if the altered VMN serotonergic activity of fafa rats
occurs early in the sequence of events initiated by the mutant fa gene.
The second objective of this study is to evaluate three possible
mechanisms for the attenuated VMN serotonergic activity in fafa rats:
(1) altered reception and/or transduction of signals arriving at the
raphe (site of origin of serotonergic projections to the VMN); (2)
altered release and/or reuptake of serotonin in the VMN; and (3) altered
input to the dorsal raphe. These mechanisms will be evaluated using in
vivo (microdialysis) and in vitro (slice) preparations from 12 wk old
Zucker fafa vs. FaFa (lean) rats.
This study will enhance our understanding of the mechanisms underlying
the altered autonomic signaling associated with the abnormal nutrient
partitioning characteristic of obesity.
人类的肥胖仍然是曼联的重大健康问题
国家。与人类和动物模型的研究已经确定
肥胖是多方面的,涉及能量消耗的改变和
能量摄入改变。最近的工作还表明了遗传
背景有助于人类肥胖的发展
说明了这种疾病的复杂性。尽管这种复杂性,
肥胖症中看到的许多代谢改变是
与交感神经和副交感神经的活性改变
神经系统。该提案重点是这一改变的一个方面
活性 - 对腹侧核(VMN)的血清素能输入
在肥胖的扎克中已显示出降低的下丘脑
老鼠。该提案的两个主要目标与
改变VMN血清素能活动的一般主题是重要的
贡献了改变能量平衡的调节的贡献者
肥胖。
这项研究的第一个目的是确定VMN是否改变
肥胖大鼠的血清素能活性发生在肥胖增加之前,
减少的热生成或高胰岛素血症。为此,我们将检查
2、4、7和12天大的Zucker/Brown Norway(ZBN)肥胖(FAFA)与精益
(fafa)幼崽。 ZBN幼崽而不是Zucker幼崽的使用允许一个
在任何年龄段
限制片段长度多态性的存在紧密联系
到FA基因座。这是ZBN混合动力车的主要优势,因为
不可能可靠地将FAFA与FAFA幼崽区分开
年龄第7天之前的扎克菌株。来自ZBN的个体发育数据
幼崽将指示FAFA大鼠的VMN血清素能活性是否改变
发生在突变FA基因引发的事件序列的早期。
这项研究的第二个目标是评估三个可能
FAFA大鼠中VMN血清素能活性减弱的机制:
(1)到达的信号的接收和/或转导的改变
Raphe(VMN的血清素能预测的起源部位); (2)
VMN中5-羟色胺的释放和/或再摄取的释放和/或再摄取; (3)改变
输入背面raphe。这些机制将使用
体内(微透析)和体外(切片)从12周旧
Zucker Fafa vs. Fafa(瘦)大鼠。
这项研究将增强我们对基本机制的理解
与养分异常相关的自主信号的改变
分配肥胖的特征。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BARBARA Ann HORWITZ其他文献
BARBARA Ann HORWITZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BARBARA Ann HORWITZ', 18)}}的其他基金
Advancing Diversity in Aging Research (ADAR) Scholars Program
推进老龄化研究多样性 (ADAR) 学者计划
- 批准号:
8795089 - 财政年份:2015
- 资助金额:
$ 3.74万 - 项目类别:
Advancing Diversity in Aging Research (ADAR) Scholars Program
推进老龄化研究多样性 (ADAR) 学者计划
- 批准号:
9127050 - 财政年份:2015
- 资助金额:
$ 3.74万 - 项目类别:
Mechanisms of Neuroprotection in the Nucleus Tractus Solitarius of Hibernators
冬眠者孤束核的神经保护机制
- 批准号:
7625397 - 财政年份:2009
- 资助金额:
$ 3.74万 - 项目类别:
相似国自然基金
脂肪组织新型内分泌因子的鉴定及功能研究
- 批准号:82330023
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
脂肪干细胞外泌体miRNA-299a-3p调控巨噬细胞Thbs1缓解脂肪组织衰老的机制研究
- 批准号:82301753
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
血管周围脂肪组织TRPV1通道通过脂联素调控肥胖相关高血压的机制研究
- 批准号:82300500
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
糖尿病脂肪组织中SIRT3表达降低进而上调外泌体miR-146b-5p促进肾小管脂毒性的机制研究
- 批准号:82370731
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
CXCL1/CXCR2信号轴上调Bcl-2促进筋膜定植巨噬细胞迁移在皮下脂肪组织原位再生中的机制研究
- 批准号:82360615
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
A mechanism of lipid accumulation in brown adipose tissue
棕色脂肪组织中脂质积累的机制
- 批准号:
10605981 - 财政年份:2023
- 资助金额:
$ 3.74万 - 项目类别:
Mechanisms of mitochondrial-ER communication during dietary and thermal induced stress
饮食和热应激期间线粒体-内质网通讯的机制
- 批准号:
10663603 - 财政年份:2023
- 资助金额:
$ 3.74万 - 项目类别:
Role of cytosolic DNA-induced sterile inflammation driving cellular and organismal progeria/aging hallmarks
细胞质 DNA 诱导的无菌炎症在驱动细胞和机体早衰/衰老标志中的作用
- 批准号:
10901042 - 财政年份:2023
- 资助金额:
$ 3.74万 - 项目类别:
Mechanisms and therapeutic potential of blocking the mitochondrial Mg2+ channel Mrs2 in obesity and NAFLD
阻断线粒体 Mg2 通道 Mrs2 在肥胖和 NAFLD 中的机制和治疗潜力
- 批准号:
10679847 - 财政年份:2023
- 资助金额:
$ 3.74万 - 项目类别: